Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2/3 1Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lung Neoplasms 3Neoplasms 2Esophageal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Suspected Central Nervous System Tumors 1Stomach Neoplasms 1Solitary Pulmonary Nodule 1Rectal Neoplasms 1Multiple Pulmonary Nodules 1Lymphedema 1Head and Neck Neoplasms 1Head and Neck Carcinoma 1Giant Cell Tumor of Bone 1Colorectal Neoplasms 1Chylothorax 1Breast Neoplasms 1

Interventions

Oxaliplatin 21Capecitabine 17Fluorouracil 15Irinotecan 11Radiotherapy 10Leucovorin 8Cetuximab 6Bevacizumab 6Gemcitabine 5oblimersen 3fludarabine 3aldesleukin 3Nivolumab 3Erlotinib Hydrochloride 3Cyclophosphamide 3labetuzumab 2dehydroftorafur 2conatumumab 2Tomography, X-Ray Computed 2Receptor Protein-Tyrosine Kinases 2Radiation 2Panitumumab 2Neoadjuvant Therapy 2Magnetic Resonance Imaging 2Interleukin-2 2Gefitinib 2Electrocardiography 2Diphenhydramine 25,10-methylenetetrahydrofolic acid 2tislelizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Rectal Neoplasms × Indocyanine Green × Clear all
NCT03204994 2019-08-13

Fluorescence Targeted Pelvic Lymph Node Mapping

Oxford University Hospitals NHS Trust

Phase 1/2 Terminated
1 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡